These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. High-dosage neuroleptic therapy for acute schizophrenic patients--two double-blind studies with benperidol. Nedopil N; Eben E; Klein H; Krüger R; Rüther E; Schmauss M Pharmacopsychiatry; 1985 Jan; 18(1):63-6. PubMed ID: 3887439 [No Abstract] [Full Text] [Related]
14. A negative, double-blind, placebo-controlled, clinical trial of verapamil in chronic schizophrenia. Grebb JA; Shelton RC; Taylor EH; Bigelow LB Biol Psychiatry; 1986 Jun; 21(7):691-4. PubMed ID: 3518822 [No Abstract] [Full Text] [Related]
15. Repeated naloxone administration in schizophrenia: a phase II World Health Organization Study. Pickar D; Bunney WE; Douillet P; Sethi BB; Sharma M; Vartanian ME; Lideman RP; Naber D; Leibl K; Yamashita I Biol Psychiatry; 1989 Feb; 25(4):440-8. PubMed ID: 2539206 [TBL] [Abstract][Full Text] [Related]
16. Treatment-resistant schizophrenia: controlled study of moderate- and high-dose thiothixene. Huang CC; Gerhardstein RP; Kim DY; Hollister L Int Clin Psychopharmacol; 1987 Jan; 2(1):69-75. PubMed ID: 3312398 [TBL] [Abstract][Full Text] [Related]
17. Repeated high dosage naloxone treatment without therapeutic efficacy in schizophrenic patients. Naber D; Leibl K Pharmacopsychiatria; 1983 Mar; 16(2):43-5. PubMed ID: 6346348 [TBL] [Abstract][Full Text] [Related]
18. Diphenylhydantoin effectiveness in the treatment of chronic schizophrenics. A double-blind controlled study with a placebo. Simopoulos AM; Pinto A; Uhlenhuth EH; McGee JJ; DeRosa ER Arch Gen Psychiatry; 1974 Jan; 30(1):106-11. PubMed ID: 4587066 [No Abstract] [Full Text] [Related]
19. Low dose bromocriptine: a study of acute effects in chronic mediated schizophrenics. Cutler NR; Jeste DV; Kaufmann CA; Karoum F; Schran HF; Wyatt RJ Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):277-83. PubMed ID: 6146164 [TBL] [Abstract][Full Text] [Related]